Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Tuesday, October 6, 2026.
EBITDA MARGIN
N/A
Market Cap
$2.41B
EBITDA Margin
7.61%
TTM Avg
16.05%
3Y Avg
16.23%
5Y Avg
20.37%
Market Cap
$2.40B
EBITDA Margin
-37.02%
TTM Avg
-37.02%
3Y Avg
-37.02%
5Y Avg
-37.02%
Market Cap
$2.40B
EBITDA Margin
-4.36%
TTM Avg
-3.80%
3Y Avg
-12.43%
5Y Avg
-17.77%
Market Cap
$2.39B
EBITDA Margin
-755.79%
TTM Avg
-753.93%
3Y Avg
-709.93%
5Y Avg
-1157.85%
Market Cap
$2.37B
EBITDA Margin
39.11%
TTM Avg
36.80%
3Y Avg
16.06%
5Y Avg
-24.25%
Market Cap
$2.33B
EBITDA Margin
-317.71%
TTM Avg
-346.77%
3Y Avg
-338.06%
5Y Avg
-349.04%
Market Cap
$2.33B
EBITDA Margin
-31.49%
TTM Avg
-441.22%
3Y Avg
-377.50%
5Y Avg
-1549.50%
Market Cap
$2.55B
EBITDA Margin
-1001.92%
TTM Avg
-694.29%
3Y Avg
-672.56%
5Y Avg
-672.56%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Disc Medicine, Inc. (IRON) | $2.42B | N/A | N/A | N/A | N/A |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.41B | 7.61% | 16.05% | 16.23% | 20.37% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.40B | -37.02% | -37.02% | -37.02% | -37.02% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | -4.36% | -3.80% | -12.43% | -17.77% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.39B | -755.79% | -753.93% | -709.93% | -1157.85% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.37B | 39.11% | 36.80% | 16.06% | -24.25% |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.33B | -317.71% | -346.77% | -338.06% | -349.04% |
| Liquidia Corporation (LQDA)vs › | $2.33B | -31.49% | -441.22% | -377.50% | -1549.50% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.55B | -1001.92% | -694.29% | -672.56% | -672.56% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.29B | 26.92% | 28.50% | 31.74% | 29.80% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
